Page last updated: 2024-08-26

1,4-dihydropyridine and Carcinoma, Squamous Cell

1,4-dihydropyridine has been researched along with Carcinoma, Squamous Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Akhtar, S; Ghosh, R; Kumar Mandal, T; Maiti, P; Manna, D; Mondal, S1
Huo, J; Li, L; Liu, W; Qin, T; Shi, X; Wang, C; Yang, D; Zhang, X; Zhang, Y; Zhou, K1
Curti, C; Garcia, CB; Goto, RN; Leopoldino, AM; Lopes, NP; Marín-Prida, J; Ochoa-Rodríguez, E; Pardo-Andreu, GL; Sobral, LM; Sousa, LO; Verdecia-Reyes, Y1
Ishibashi, T; Nishio, M; Yoshida, J1

Other Studies

4 other study(ies) available for 1,4-dihydropyridine and Carcinoma, Squamous Cell

ArticleYear
Anticancer activity of a 1,4-dihydropyridine in DMBA-induced mouse skin tumor model.
    Anti-cancer drugs, 2020, Volume: 31, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Calcium Channel Blockers; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Dihydropyridines; Male; Mice; Organ Size; Skin Neoplasms; Tumor Cells, Cultured

2020
Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 96

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Dihydropyridines; Drug Resistance; Esophageal Neoplasms; G2 Phase Cell Cycle Checkpoints; Humans; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Small Molecule Libraries

2017
Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma.
    European journal of pharmacology, 2018, Jan-15, Volume: 819

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydropyridines; Gene Expression Regulation, Neoplastic; Genes, myc; Head and Neck Neoplasms; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondrial Size; Neoplasm Invasiveness; Neovascularization, Pathologic; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays

2018
G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells.
    Biochemical pharmacology, 2007, Apr-01, Volume: 73, Issue:7

    Topics: Amlodipine; Calcium Channel Blockers; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinases; Dihydropyridines; G1 Phase; Humans; Nuclear Proteins; Phosphorylation; Repressor Proteins; Tumor Cells, Cultured

2007